An Unexpected Fight: A Pediatric Cancer podcast
Our podcast delves into the challenging journey of pediatric cancer, exploring topics such as diagnosis, treatment, fundraising, and addressing common questions. Each episode sheds light on hospital experiences, mental health struggles, and financial hardships. We invite families of pediatric cancer warriors, pediatric oncologists, researchers, representatives from non-profits, and those who have lost children to join us and share their stories. Whether the battle has been won, is ongoing, or ended in loss, we aim to amplify the voices of those affected by pediatric cancer and honor the memories of children who fought bravely.
You can also get involved with the National Pediatric Cancer Foundation through fundraising, volunteering, promoting awareness, or contributing to pediatric cancer research. Visit nationalpcf.org for more information about the foundation
To contact Tiffany, please email tmcconathy@nationalpcf.org
To contact Kelly, please email kgoddard@nationalpcf.org
An Unexpected Fight: A Pediatric Cancer podcast
Dr. Claire Carter
Claire L. Carter, Ph.D., is an Assistant Member of the Center for Discovery and Innovation; Assistant Professor of Pathology at Hackensack Meridian School of Medicine; and Co-Director of the Mass Spectrometry and Analytical Pharmacology Shared Resource at the NCI-designated Georgetown Lombardi Comprehensive Cancer Center.
Dr. Carter completed her Ph.D. in Chemistry at the University of Birmingham, UK, under the supervision of Professor Josephine Bunch. She then moved to the US for a postdoctoral appointment at the University of Maryland Baltimore, where she worked on normal tissue radiation injury. At the Hackensack Meridian Center for Discovery and Innovation, Dr. Carter has built a translational pediatric neuro-oncology research program in partnership with Dr. Derek Hanson, Director of Pediatric Neuro-oncology, Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center.
Dr. Carter possesses a rare translational background that combines expertise in bioanalytical chemistry, clinical histopathology and biomedical science. Her group are using next generation imaging techniques to develop a deep understanding of the biological and transitional states of tumor cells as shaped by their spatiotemporal location within patient tumors and preclinical models. Their focus is on targeting lipid signaling and metabolism for less toxic and more efficacious treatments in highly aggressive pediatric brain tumors. In addition to using mass spectrometry imaging for intratumoral pharmacokinetic/pharmacodynamic (PK/PD) studies to identify more efficacious treatment regimens that can be rapidly translated into clinic gain.
You can also get involved with the Gold Ribbon Kids Cancer Foundation or the National Pediatric Cancer Foundation through fundraising, volunteering, promoting awareness, or contributing to pediatric cancer research. Visit goldribbon-kids.org or nationalpcf.org for more information
To contact Tiffany, please email info@goldribbon-kids.org
To contact Kelly, please email kgoddard@nationalpcf.org
